Quote | GBS Inc. (NASDAQ:GBS)
Last: | $0.4732 |
---|---|
Change Percent: | -1.57% |
Open: | $0.4808 |
Close: | $0.4732 |
High: | $0.4854 |
Low: | $0.4507 |
Volume: | 9,030 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | GBS Inc. (NASDAQ:GBS)
GBS ( NASDAQ: GBS ) said Tuesday it acquired Intelligent Fingerprinting (IFP), expanding the GBS platform of rapid, non-invasive diagnostic testing technologies and its geographical reach. GBS also began the process of changing its corporate name. GBS issued ~3M shares...
The transaction further solidifies GBS’ leadership in non-invasive, real-time diagnostic testing with an expanded portfolio and geographical reach GBS’ global footprint includes operations in Australia, United Kingdom and the US NEW YORK, Oct. 04, 2022 (G...
Message Board Posts | GBS Inc. (NASDAQ:GBS)
Subject | By | Source | When |
---|---|---|---|
$GBS~.58~NO REVERSE SPLIT, plenty time until end | ALERTS100%to10000%GAIN | investorshub | 05/27/2022 4:21:11 AM |
$GBS: .59,, Valuation $4.50 Third Quarter | ALERTS100%to10000%GAIN | investorshub | 05/27/2022 4:02:18 AM |
$GBS~.59,~$4.00++ pps coming,,https://s27.q4cdn.com/906368049/files/News/2022/Zac | ALERTS100%to10000%GAIN | investorshub | 05/27/2022 3:59:23 AM |
CapitalGainsReport: New Report Suggest Healthcare Tech Will Lead | ALERTS100%to10000%GAIN | investorshub | 04/29/2022 10:41:33 AM |
$GBS~.82,,~bullish stochastics ,gonna break hard soon,,https://stockcharts | ALERTS100%to10000%GAIN | investorshub | 04/22/2022 2:26:16 AM |
News, Short Squeeze, Breakout and More Instantly...
GBS Inc. Company Name:
GBS Stock Symbol:
NASDAQ Market:
The transaction further solidifies GBS’ leadership in non-invasive, real-time diagnostic testing with an expanded portfolio and geographical reach GBS’ global footprint includes operations in Australia, United Kingdom and the US NEW YORK, Oct. 04, 2022 (G...
- Entered into exclusive agreement with Intelligent Fingerprinting Ltd. (IFP) for screening technology focused on drugs of abuse towards a prospective acquisition - - Completed collection and analysis in a study with coincidental sampling of oral fluid and blood to evaluate the ...
NEW YORK, Aug. 29, 2022 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point-of-care, today announced that it will release its financial results for the four...